|
SPOPL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.193550E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.022950E-03 |
| Normal-vs-Stage2 |
4.711800E-01 |
| Normal-vs-Stage3 |
3.835800E-01 |
| Normal-vs-Stage4 |
2.473000E-01 |
| Stage1-vs-Stage2 |
3.804000E-01 |
| Stage1-vs-Stage3 |
3.291200E-01 |
| Stage1-vs-Stage4 |
9.004400E-01 |
| Stage2-vs-Stage3 |
9.842400E-01 |
| Stage2-vs-Stage4 |
6.603600E-01 |
| Stage3-vs-Stage4 |
6.557000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.760350E-02 |
| Normal-vs-AfricanAmerican |
5.380300E-02 |
| Normal-vs-Asian |
1.671920E-02 |
| Caucasian-vs-AfricanAmerican |
8.613400E-01 |
| Caucasian-vs-Asian |
5.755600E-01 |
| AfricanAmerican-vs-Asian |
5.854800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.303170E-03 |
| Normal-vs-Female |
9.532200E-01 |
| Male-vs-Female |
1.826270E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.721300E-03 |
| Normal-vs-Extreme_Weight |
1.591290E-04 |
| Normal-vs-Obese |
3.089200E-01 |
| Normal-vs-Extreme_Obese |
1.682210E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.232200E-01 |
| Normal_Weight-vs-Obese |
8.486400E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.230600E-01 |
| Extreme_Weight-vs-Obese |
3.362100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.777600E-01 |
| Obese-vs-Extreme_Obese |
4.318800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.995000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.073200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.058270E-03 |
| Normal-vs-Age(81-100Yrs) |
4.166200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.702200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.215230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.211440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.668200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.030400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.599800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.924800E-03 |
| Normal-VS-Type2 PRCC |
3.024800E-04 |
| Normal-VS-KIRP CIMP |
3.816200E-01 |
| Normal-VS-Unclassified PRCC |
6.769800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.694150E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.044100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.308950E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.529600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.623600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.130200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.405200E-04 |
| Normal-vs-N1 |
4.827200E-01 |
| Normal-vs-N2 |
4.281700E-02 |
| N0-vs-N1 |
2.843500E-02 |
| N0-vs-N2 |
9.868400E-01 |
| N1-vs-N2 |
3.331400E-01 |
|
|
